Welcome to our dedicated page for Butterfly Network news (Ticker: BFLY), a resource for investors and traders seeking the latest updates and insights on Butterfly Network stock.
Butterfly Network, Inc. (BFLY) is revolutionizing the healthcare landscape with its innovative digital health solutions, primarily focused on handheld, whole-body ultrasound technology. The company, which operates at the nexus of advanced engineering and scientific disciplines, has assembled a team of world-class talents in computer science, physics, and electrical engineering. Underpinned by a robust financial foundation from a select group of highly successful serial entrepreneurs, Butterfly Network is uniquely positioned to dedicate its full attention to product and intellectual property development.
Butterfly Network's flagship product, the Butterfly iQ+, represents a significant leap in medical imaging technology. This compact, user-friendly device leverages the company's proprietary Ultrasound-on-Chip technology to enable healthcare professionals to perform comprehensive whole-body imaging using a single handheld probe. The device's affordability and portability make it a game-changer in clinical settings, ensuring that high-quality ultrasound imaging is accessible and practical for a wide range of medical applications.
The integration of cloud-connected software with hardware technology further enhances the utility of the Butterfly iQ+, allowing for seamless data acquisition and analysis via a mobile application. This connectivity facilitates the practical application of ultrasound information within clinical workflows, thereby improving diagnostic capabilities and patient outcomes.
Recent achievements and ongoing projects include advancements in ultrasound technology and the expansion of the product's applications in various medical fields. The company's commitment to innovation is reflected in its continuous efforts to enhance the performance and capabilities of its devices.
With a strong focus on R&D and a strategic approach to technological development, Butterfly Network is poised to make significant contributions to digital health and medical imaging. The company's progress and updates can be closely followed through the latest news and press releases, which provide valuable insights into its performance, events, and developments.
Butterfly Network, Inc. (BFLY) has announced that it will report its second quarter 2021 financial results on August 9, 2021, before market open. The company's leadership, including Dr. Todd Fruchterman and Stephanie Fielding, will host a conference call at 8:30 a.m. ET the same day to discuss the results and operational advancements. Butterfly Network is known for its innovative, affordable, handheld ultrasound technology aimed at improving global health equity.
Butterfly Network, Inc. (NYSE: BFLY) has appointed Dr. Andrei Stoica as Chief Technology Officer and David Ramsey as Chief Information Officer, effective July 19. Dr. Stoica will oversee product development and technology innovation, reporting to President and CEO Todd Fruchterman. With extensive experience at BioTelemetry and IQVIA, Dr. Stoica aims to drive advancements in ultrasound technology. Ramsey brings a strong IT background, focusing on security and infrastructure. Both executives are expected to enhance Butterfly's mission of democratizing medical imaging globally.
Butterfly Network (NYSE: BFLY) announced its participation in the Cowen 6th Annual FutureHealth Conference, a virtual event on June 16-17, 2021. Dr. Todd Fruchterman, the President and CEO, along with CFO Stephanie Fielding and CMO Dr. John Martin, will discuss 'Handheld Point-of-Care Ultrasound' on June 16 at 2:35 p.m. ET. The conversation will be available via the investor relations section of Butterfly Network's website. Butterfly, founded in 2011, aims to democratize medical imaging using its innovative Butterfly iQ system, promoting health equity for the 4.7 billion people lacking ultrasound access.
Butterfly Network (NYSE: BFLY) has announced the establishment of its new corporate headquarters in Burlington, Massachusetts. This move will accommodate around 275 employees and aims to foster growth and innovation in medical imaging technology. The project is set for completion in Q1 2022, with temporary offices already in use. Town officials emphasize Burlington's appeal for economic development, citing collaboration opportunities with local medical institutions. Butterfly, known for its handheld ultrasound technology, continues its mission to enhance global health equity.
On June 3, the SpaceX Dragon cargo resupply mission will deliver a Butterfly iQ to the International Space Station. Developed by Butterfly Network (BFLY), this handheld ultrasound device aims to enhance astronaut healthcare by allowing self-monitoring for conditions like kidney stones and blood clots. The Translational Research Institute for Space Health (TRISH) supports user demonstrations in space, emphasizing the technology's portability and reliability. Butterfly Network seeks to democratize medical imaging globally, providing accessible ultrasound solutions for various healthcare settings.
Butterfly Network (NYSE: BFLY) announced that its second-generation iQ+ received a Class III Medical Device License in Canada. The iQ+ features innovative Ultrasound-on-Chip technology and enhancements for improved usability. The device is designed to support advanced medical imaging with features like real-time Biplane Imaging and enhanced battery life. The company anticipates strong demand in Canada, following the success of its first-generation device launched in 2020. With this approval, Butterfly iQ+ will be available in 20 countries, aiming to enhance medical imaging accessibility.
Butterfly Network, Inc. (NYSE: BFLY) reported financial results for Q1 2021, achieving $12.4 million in revenue, a 43.5% increase from Q1 2020. The gross profit was $6.4 million with a gross margin of 51.6%. Operating expenses rose to $60.2 million, a 154.1% increase year-over-year, leading to a net loss of $0.7 million, down from $24.4 million in 2020. The company forecasts 2021 revenue of $76 million to $80 million, projecting 64% to 73% growth year-over-year, while expecting a net loss of $135 million to $155 million.
Butterfly Network (NYSE: BFLY) will announce its first quarter 2021 financial results on May 13, 2021, prior to market opening. CEO Todd Fruchterman and CFO Stephanie Fielding will hold a conference call at 8:30 a.m. ET on the same day to discuss the results and operational updates. The call will be available as a live webcast, and a replay will be accessible until May 20, 2021. Butterfly Network aims to democratize medical imaging and enhance global health equity through its innovative handheld ultrasound technology, the Butterfly iQ+.
Butterfly Network (NYSE: BFLY) has appointed Timothy Trodden as Senior Vice President and Chief Human Resources Officer, effective April 19. In this new role, Trodden will lead the company's people strategy, focusing on talent acquisition, cultural development, and enhancing HR practices to align with business growth. Dr. Todd Fruchterman, President and CEO, emphasized the importance of investing in talent as crucial for Butterfly's success. Trodden brings extensive experience from WellCare Health Plans and Johnson & Johnson, where he focused on talent strategy and diversity initiatives.
Butterfly Network (BFLY) reported a 68% revenue increase for 2020, reaching $46.3 million from $27.6 million in 2019. The company saw a 53% rise in product revenue, totaling $38.4 million. Subscription revenues surged 216% to $7.9 million. However, net losses widened to ($162.7 million), compared to ($99.7 million) in 2019. The company attributes growth to the launch of its next-gen probe, the iQ+, and increased sales efforts. Cash reserves stood at $60.2 million as of December 31, 2020, laying a foundation for future growth.
FAQ
What is the current stock price of Butterfly Network (BFLY)?
What is the market cap of Butterfly Network (BFLY)?
What is Butterfly Network, Inc.?
What product does Butterfly Network offer?
How does the Butterfly iQ+ work?
What makes Butterfly Network's technology unique?
Who funds Butterfly Network?
What are the recent achievements of Butterfly Network?
How does Butterfly Network contribute to healthcare?
Is Butterfly Network publicly traded?
Can the Butterfly iQ+ be used in multiple medical settings?